Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011065

Director sold 6,000 shares at $65.08 ($390,480)

  • Director acquired 6,000 shares (option exercise)
  • Director acquired 1,504 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GRIFFIN MICHELLE RENEE Director 2021-02-14 Grant or award +1,504 1,504 D
GRIFFIN MICHELLE RENEE Director 2021-02-16 Option exercise +6,000 $7.80 $46,800 7,504 D
GRIFFIN MICHELLE RENEE Director 2021-02-16 Sale −6,000 $65.08 $390,480 1,504 D
Derivatives
GRIFFIN MICHELLE RENEE Director 2021-02-14 Grant or award · Stock Option (Right to Buy) +3,759 3,759 D
GRIFFIN MICHELLE RENEE Director 2021-02-16 Option exercise · Stock Option (Right to Buy) −6,000 89,000 D
Open-market sales · 6,000 sh · avg $65.08 · $390,480
Loading xslF345X03/doc4.xml…